0000919574-23-004847.txt : 20230814
0000919574-23-004847.hdr.sgml : 20230814
20230814205153
ACCESSION NUMBER: 0000919574-23-004847
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230810
FILED AS OF DATE: 20230814
DATE AS OF CHANGE: 20230814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kynam Capital Management, LP
CENTRAL INDEX KEY: 0001907884
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40791
FILM NUMBER: 231172981
BUSINESS ADDRESS:
STREET 1: 221 ELM ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 212-659-3970
MAIL ADDRESS:
STREET 1: 221 ELM ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 2seventy bio, Inc.
CENTRAL INDEX KEY: 0001860782
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 863658454
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02210
BUSINESS PHONE: 339-499-9300
MAIL ADDRESS:
STREET 1: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02210
4
1
ownership.xml
X0508
4
2023-08-10
0
0001860782
2seventy bio, Inc.
TSVT
0001907884
Kynam Capital Management, LP
221 ELM ROAD
PRINCETON
NJ
08540
0
0
1
0
0
Common Stock, par value $0.0001 per share
2023-08-10
4
P
0
179000
5.94
A
5703825
I
See Footnote
Common Stock, par value $0.0001 per share
2023-08-10
4
P
0
50000
5.80
A
5753825
I
See Footnote
Common Stock, par value $0.0001 per share
2023-08-10
4
P
0
100000
5.85
A
5853825
I
See Footnote
Common Stock, par value $0.0001 per share
2023-08-10
4
P
0
100000
5.96
A
5953825
I
See Footnote
Common Stock, par value $0.0001 per share
2023-08-10
4
P
0
86414
5.96
A
5142111
D
Common Stock, par value $0.0001 per share
2023-08-10
4
P
0
86414
5.96
A
5142111
I
See Footnote
The reported securities are owned directly by Kynam Global Healthcare Master Fund, LP (the "Master Fund"), a private investment fund managed by Kynam Capital Management, LP (the "Adviser"), and separately managed account clients of the Adviser and may be deemed to be indirectly beneficially owned by (i) the Adviser, (ii) Kynam Capital Management GP, LLC (the "Adviser GP"), the general partner of the Adviser and (iii) Yue Tang, the managing member of the Adviser GP. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
The reported securities are directly owned by the Master Fund. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
The reported securities are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by Kynam Fund GP, LLC, the general partner of the Master Fund. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
KYNAM CAPITAL MANAGEMENT, LP, By: KYNAM CAPITAL MANAGEMENT GP, LLC, By: /s/ Yue Tang, Yue Tang, Managing Member
2023-08-14